ketanserin has been researched along with Albuminuria in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
Excerpt | Relevance | Reference |
---|---|---|
"Ten patients with essential hypertension and normal renal function were treated with ketanserin (20-40 mg twice a day), administered for 8 weeks." | 7.68 | Antihypertensive therapy with ketanserin: effects on central and renal hemodynamics, and microalbuminuria. ( Bedogna, V; Casagrande, P; Giorgetti, P; Graziani, MS; Loschiavo, C; Maschio, G; Valvo, E, 1990) |
"Ten patients with essential hypertension and normal renal function were treated with ketanserin (20-40 mg twice a day), administered for 8 weeks." | 3.68 | Antihypertensive therapy with ketanserin: effects on central and renal hemodynamics, and microalbuminuria. ( Bedogna, V; Casagrande, P; Giorgetti, P; Graziani, MS; Loschiavo, C; Maschio, G; Valvo, E, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casagrande, P | 1 |
Valvo, E | 1 |
Bedogna, V | 1 |
Loschiavo, C | 1 |
Giorgetti, P | 1 |
Graziani, MS | 1 |
Maschio, G | 1 |
1 other study available for ketanserin and Albuminuria
Article | Year |
---|---|
Antihypertensive therapy with ketanserin: effects on central and renal hemodynamics, and microalbuminuria.
Topics: Adult; Albuminuria; Cardiac Output; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypert | 1990 |